OptimizeRx Corporation (OPRX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    OptimizeRx Corporation

    NASDAQ: OPRX · Real-Time Price · USD
    18.83
    1.27 (7.23%)
    At close: Sep 11, 2025, 3:59 PM
    18.52
    -1.65%
    After-hours: Sep 11, 2025, 07:57 PM EDT

    OptimizeRx Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 92.13M 71.52M 62.45M 61.29M
    Cost of Revenue
    		 32.75M 28.62M 23.48M 25.65M
    Gross Profit
    		 59.38M 42.9M 38.97M 35.64M
    Operating Income
    		 -13.71M -26.4M -12.29M 361.1K
    Interest Income
    		 329K 2.19M 852.3K 16.98K
    Pretax Income
    		 -19.39M -25.16M -11.44M 378.08K
    Net Income
    		 -20.11M -17.57M -11.44M 378.08K
    Selling & General & Admin
    		 61.27M 53.72M 49.24M 33.19M
    Research & Development
    		 n/a n/a n/a n/a
    Other Expenses
    		 11.82M 15.58M 2.02M 2.09M
    Operating Expenses
    		 73.08M 69.3M 51.26M 35.28M
    Interest Expense
    		 6.16M 1.45M n/a n/a
    Selling & Marketing Expenses
    		 n/a -4.3M n/a 5.68M
    Cost & Expenses
    		 105.83M 97.92M 74.74M 60.93M
    Income Tax Expense
    		 725K -7.6M n/a n/a
    Shares Outstanding (Basic)
    		 18.29M 17.12M 17.78M 17.23M
    Shares Outstanding (Diluted)
    		 18.29M 17.12M 17.78M 17.69M
    EPS (Basic)
    		 -1.1 -1.03 -0.64 0.02
    EPS (Diluted)
    		 -1.1 -1.03 -0.64 0.02
    EBITDA
    		 -8.9M -21.31M -9.42M 2.33M
    EBIT
    		 -13.22M -23.71M -11.44M 361.1K
    Depreciation & Amortization
    		 4.33M 2.4M 2.02M 1.97M

    Add to Watchlist